OTC Markets OTCPK - Delayed Quote USD

TC Biopharm (Holdings) Plc (TCBWF)

0.0080
-0.0009
(-10.11%)
At close: May 12 at 10:51:28 AM EDT
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
3,844.5320
1,978.6590
Operating Expense
12,767.6700
12,767.6700
14,239.3230
15,928.5290
9,259.3020
Operating Income
-12,767.6700
-12,767.6700
-14,239.3230
-12,083.9970
-7,280.6430
Net Non Operating Interest Income Expense
0
0
-83.0250
-6,753.2310
-3,438.5150
Other Income Expense
-38.3310
-38.3310
7,326.6660
15,803.6270
-4,264.3090
Pretax Income
-12,806.0010
-12,806.0010
-6,995.6820
-3,033.6010
-14,983.4670
Tax Provision
-651.9710
-651.9710
-1,088.7290
-1,720
-1,407.5420
Net Income Common Stockholders
-12,154.0300
-12,154.0300
-5,906.9530
-1,313.6010
-13,575.9250
Diluted NI Available to Com Stockholders
-12,154.0300
-12,154.0300
-5,906.9530
-1,313.6010
-13,575.9250
Total Operating Income as Reported
-12,767.6700
-12,767.6700
-14,239.3230
-12,083.9970
--
Total Expenses
12,767.6700
12,767.6700
14,239.3230
15,928.5290
9,259.3020
Net Income from Continuing & Discontinued Operation
-12,154.0300
-12,154.0300
-5,906.9530
-1,313.6010
-13,575.9250
Normalized Income
-12,166.7829
-12,166.7829
-12,160.9882
-14,212.5278
-9,712.2038
Interest Income
--
--
--
2.2080
0.0330
Interest Expense
0
0
83.0250
6,753.2310
3,438.5480
Net Interest Income
0
0
-83.0250
-6,753.2310
-3,438.5150
EBIT
-12,806.0010
-12,806.0010
-6,912.6570
3,719.6300
-11,544.9190
EBITDA
-12,371.7320
-12,371.7320
-6,279.6490
4,489.2260
-10,519.8610
Reconciled Depreciation
434.2690
434.2690
633.0080
769.5960
1,025.0580
Net Income from Continuing Operation Net Minority Interest
-12,154.0300
-12,154.0300
-5,906.9530
-1,313.6010
-13,575.9250
Total Unusual Items Excluding Goodwill
13.4370
13.4370
7,406.7360
15,924.6010
-4,264.3090
Total Unusual Items
13.4370
13.4370
7,406.7360
15,924.6010
-4,264.3090
Normalized EBITDA
-12,385.1690
-12,385.1690
-13,686.3850
-11,435.3750
-6,255.5520
Tax Rate for Calcs
0.0001
0.0001
0.0002
0.0002
0.0001
Tax Effect of Unusual Items
0.6841
0.6841
1,152.7008
3,025.6742
-400.5878
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ESLAW Estrella Immunopharma, Inc.
0.0425
-22.73%
 
SLXNW Silexion Therapeutics Corp
0.0412
-0.24%
 
COEPW Coeptis Therapeutics Holdings, Inc.
0.0323
+0.31%
 
DRMAW Dermata Therapeutics, Inc.
0.0137
-44.98%
 
APLMW Apollomics, Inc.
0.0150
+0.67%
 
LIXTW Lixte Biotechnology Holdings, Inc.
0.0392
+51.94%
 
GOVXW GeoVax Labs, Inc.
0.0436
0.00%
 
NLSPW NLS Pharmaceutics AG
0.0179
+326.19%
 
CDTTW Conduit Pharmaceuticals Inc.
0.0098
+4.26%
 
CEROW CERo Therapeutics Holdings, Inc.
0.0119
-36.70%